Clinical Trial

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2025-08-04; most recent amendment 2026-07-06.
Status change: Not Yet Recruiting → Recruiting 2025-08-20
Trial Details
NCT Number NCT07115043
Lead Sponsor AstraZeneca
Conditions Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma (Skin), Renal Cell Carcinoma, Merkel Cell Carcinoma, Triple Negative Breast Cancer, Head and Neck Squamous Cell Carcinoma, Gastric Cancer/Gastroesophageal Junction Cancer +1 more
Enrollment 60 participants
Start Date 2025-07-29
Primary Completion 2029-10-02 (estimated)
Study Completion 2029-10-02 (estimated)
Updated on ClinicalTrials.gov 2026-07-07